✦ LIBER ✦

Methylation as a Mechanism of Cisplatin Resistance in Head and Neck Cancer

✍ Scribed by Viet, C.T.; Dang, D.; Ye, Y.; Schmidt, B.L.

Book ID: 123461192
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 57 KB
Volume: 71
Category: Article
ISSN: 1531-5053
DOI: 10.1016/j.joms.2013.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylation as a biomarker for head and

Methylation as a biomarker for head and neck cancer

✍ Arantes, L.M.R.B.; de Carvalho, A.C.; Melendez, M.E.; Carvalho, A.L.; Goloni-Ber 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Cisplatin as a radiosensitizer in the tr

Cisplatin as a radiosensitizer in the treatment of locally advanced head and neck cancer

✍ Ozden Altundag; Kadri Altundag; Paolo Morandi; Emer Hanrahan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Cisplatin, fluorouracil, docetaxel in he

Cisplatin, fluorouracil, docetaxel in head and neck cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 142 KB

Mechanisms of resistance to EGFR inhibit

Mechanisms of resistance to EGFR inhibitors in head and neck cancer

✍ Jonathan B. Cooper; Ezra Eddy Wyssam Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Epidermal growth factor receptor (EGFR), a receptor tyrosine kinase that activates multiple signaling pathways, including phosphatidylinositol‐3‐kinase/v‐AKT murine thymoma viral oncogene homolog protein (Akt), has long been a target of novel therapies. Despite universal EGFR expression

Role of DNA methylation in head and neck

Role of DNA methylation in head and neck cancer

✍ Semra Demokan; Nejat Dalay 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 570 KB

Mitochondria as a critical target of the

Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer

✍ Kevin J. Cullen; Zejia Yang; Lisa Schumaker; Zhongmin Guo 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 195 KB